INTELLIGENT SCIENCE
DRIVEN TO
DETECT + PREVENT
We are relentless in our pursuit to find the right science and technology to conquer some of the biggest challenges in healthcare. Our approach is to discover and explore any angle that leads to the best answer.
Leading the TRANSFORMATION
of Data into Diagnostics
Our mission is to invent and distribute technology that can save lives through detection of subclinical diseases that affect our population the most. We develop, manufacture and distribute unique diagnostic tests that can address the most challenging unmet clinical needs.
Our PULS Cardiac Test™ identifies the vulnerable patient that is missed by current conventional tests to facilitate timely intervention and prevention that improves cardiac patient care. The PULS (Protein Unstable Lesion Signature) Test is a personalized 5-year heart attack risk that measures protein biomarkers of the body's inflammatory immune response to arterial injury caused by free radicals, infection or toxins. This injury may lead to the formation of unstable lesion plaques. These unstable lesion plaques are the most common cause of heart attacks and strokes- contrary to the common believe that narrowing of the arteries is the cause.
DETECTING CARDIOVASCULAR DISEASE
We partner with leaders in technological development in healthcare to change the way the medical industry works. Our goal is to proactively intervene and prevent disease.
EMPOWERING
PARTNERSHIPS
Our DiabetesPredict™ test offers a new way to identify Type 2 Diabetes risk before symptoms or abnormal labs are discovered.
PREVENTING DIABETES
Our team is comprised of healthcare entrepreneurs, scientists and innovators with many decades of achievements in building high value enterprises developing life-saving products and technologies and driving successful commercialization and sales strategies.
OUR
LEADERSHIP
EARLY + ACCURATELY DETECT
HEART DISEASE
THE PULS CARDIAC TEST very accurately detects and measures the level of coronary heart disease present in the human body as well as provides the absolute risk of a patient experiencing a heart attack over the ensuing five years
OUR TEAMS USE THEIR SCIENTIFIC EXPERTISE TO PRACTICE INNOVATION DRIVEN BY ROBUST RESEARCH AND CUTTING-EDGE SCIENCE.
TYPE 2 DIABETES
PREVENTION & INTERVENTION
THE FIRST GENETIC TEST THAT EVALUATES GENETIC RISK OF DEVELOPING TYPE 2 DIABETES.
From genetic risk assessment to diabetes clinical intervention, DIABETESpredict integrates the individual's ancestry, family history and anthropometric variables to guide the physician in clinical and lifestyle intervention.
WE PROVIDE PHYSICIANS
THE MOST-ADVANCED TOOLS TO DETECT, PREVENT AND PROVIDE SUPERIOR TREATMENT.
Diagnostic
Testing
Services
CUTTING-EDGE MEDICAL RESEARCH + DIAGNOSTICS
TO TRANSFORM HEALTHCARE
As a pioneer in the field of diagnostic medicine, we work on the cutting edge of medical research, turn discoveries into innovative products and bring those products to the global marketplace.
Our advanced research teams develop, manufacture, and distribute innovative technology platforms to address the needs of the global disease burden.
Our CLIA-certified and GMP laboratory performs a menu of clinically effective tests targeting key health issues. our goal is to equip physicians with the tools they need to transform health care - one patient at a time.
COLLABORATION OPPORTUNITIES
If you would like to work with us in a particular research area, or if you are interested in commercializing your clinical product please submit a proposal.
OUR FAMILY OF COMPANIES
